[144] Performance Food Group Company SEC Filing

Rhea-AI Filing Summary

IonQ, Inc. (Form 144) discloses a planned sale of 6,789 common shares through Morgan Stanley Smith Barney on or about 07/11/2025. The shares have an aggregate market value of $311,818.77 and represent an immaterial ~0.003% of the 247.8 million shares outstanding. The securities were acquired as restricted stock units on 07/11/2025. 

The filing also lists prior 10b5-1 program transactions for the same account holder—30,696 shares sold in the past three months for total proceeds of $1.27 million (25,696 shares on 06/11/2025 and 5,000 shares on 07/07/2025). 

Form 144 serves only as advance notice and does not guarantee the sale will occur. The share count and dollar amounts involved are small relative to IonQ’s float, suggesting limited direct market impact, yet ongoing insider selling can be monitored by investors for sentiment signals.

Insights

Securities Analyst

TL;DR insider plans to sell 6,789 shares; scale appears immaterial.

Form 144 indicates a routine sale under Rule 144 and possibly linked to an established 10b5-1 plan. The dollar value ($312k) is negligible versus IonQ’s market capitalization and float, so liquidity impact is minimal. Nevertheless, cumulative sales of ~37k shares since June may draw attention from investors tracking insider sentiment. Absent other disclosures, the event is neutral for valuation.

Risk Analyst

TL;DR small insider sale; monitor frequency rather than size.

Insider activity itself is not a red flag, particularly under a 10b5-1 plan. The filing affirms the seller is unaware of undisclosed adverse information, reducing information-asymmetry risk. Still, repeated divestitures within a short window can influence perception if they persist. Overall, the filing is not materially impactful to IonQ’s risk profile.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7865	711231.95	156090902	07/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/11/2025	Exercise of Stock Options	Issuer			7865	07/11/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRENT KING 12500 West Creek Parkway Richmond VA 23238	Common	05/29/2025	12866	1158270.37
10b5-1 Sales for BRENT KING 12500 West Creek Parkway Richmond VA 23238	Common	05/28/2025	11104	984801.91

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many IonQ (IONQ) shares are proposed for sale in this Form 144?

The notice covers 6,789 common shares.

What is the estimated value of the shares referenced in IonQ’s Form 144?

The aggregate market value is $311,818.77.

When is the anticipated sale date for the IonQ shares?

The approximate sale date listed is 07/11/2025.

How many IonQ shares were sold by the filer in the past three months?

A total of 30,696 shares were sold, generating $1.27 million in gross proceeds.

Does the planned sale materially affect IonQ’s share count?

No. The 6,789 shares represent about 0.003% of the 247.8 million shares outstanding.